High fluence PACK-CXL as adjuvant treatment for advanced Acanthamoeba keratitisShow others and affiliations
2019 (English)In: American journal of ophthalmology case reports, ISSN 2451-9936, Vol. 15, article id 100499Article in journal (Refereed) Published
Abstract [en]
Purpose
To describe the outcome of adjuvant high fluence photoactivated chromophore for infectious keratitis cross-linking (PACK-CXL) used to treat an advanced form of refractory Acanthamoeba keratitis (AK) diagnosed several months after initial presentation.
Observations
An otherwise healthy 24-year old female presented with a severe unilateral keratitis. The diagnosis eluded clinicians for several months and when finally confirmed as AK, anti-amoebic therapy was instated and only appeared to be effective after addition of high fluence PACK-CXL.
Conclusion and importance
In this case of advanced AK, high fluence PACK-CXL treatment given adjuvant to pharmacologic anti-amoebic therapy resulted in lasting pain relief, re-epithelization and eradication of the Acanthamoeba parasite. Given adjuvant to anti-amoebic pharmacotherapy, high fluence PACK-CXL might be a useful method for treating typically refractory advanced AK.
Place, publisher, year, edition, pages
Elsevier, 2019. Vol. 15, article id 100499
Keywords [en]
Acanthamoeba keratitis; Phototherapy
National Category
Polymer Chemistry
Identifiers
URN: urn:nbn:se:liu:diva-164808DOI: 10.1016/j.ajoc.2019.100499PubMedID: 31312750Scopus ID: 2-s2.0-85068180159OAI: oai:DiVA.org:liu-164808DiVA, id: diva2:1420918
2020-04-012020-04-012020-04-23Bibliographically approved